Patents by Inventor Carsten Andersen

Carsten Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alpha-amylase variants and polynucleotides encoding same
    Patent number: 11384347
    Abstract: The present invention relates to alpha-amylase variants comprising substitutions at positions corresponding to positions 268 and 293 of SEQ ID NO: 1, in particular substitutions selected from the group consisting of: 268G+293Y; 268G+293F; 268G+293W; 268G+293H; 268G+293A; 268G+293Q; 268A+293Y; 268A+293F; 268A+293W; 268A+293H; 268A+293A; 268A+293Q; 268P+293Y; 268P+293F; 268P+293W; 268P+293H; 268P+293A; 268P+293Q; 268S+293Y; 268S+293F; 268S+293W; 268S+293H; 268S+293A; 268S+293Q; 268T+293Y; 268T+293F; 268T+293W; 268T+293H; 268T+293A; 268T+293Q; 268V+293Y; 268V+293F; 268V+293W; 268V+293H; 268V+293A; 268V+293Q; 268I+293Y; 268I+293F; 268I+293W; 268I+293H; 268I+293A; 268I+293Q; 268L+293Y; 268L+293F; 268L+293W; 268L+293H; 268L+293A; 268L+293Q; 268M+293Y; 268M+293F; 268M+293W; 268M+293H; 268M+293A; 268M+293Q; and wherein the variant has at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to a
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: July 12, 2022
    Assignee: NOVOZYMES A/S
    Inventors: Carsten Andersen, Lars Giger, Johanne Mørch Jensen, Louis Patrick Lessard
  • Alpha-amylase variants and polynucleotides encoding same
    Patent number: 11365375
    Abstract: The present invention relates to alpha-amylase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: June 21, 2022
    Assignee: NOVOZYMES A/S
    Inventors: Carsten Andersen, Vivek Srivastava, Padmavathi Balumuri, Partha Pratim Chakrabarti, Sohel Dalal
  • Alpha-amylase variants and polynucleotides encoding same
    Patent number: 11326153
    Abstract: The present invention relates to alpha-amylase variants comprising a substitution at a position corresponding to position 188 and at least one further substitution at a position corresponding to position 242 or 279 or 275 of SEQ ID NO: 1, in particular one or more combinations of substitutions selected from the group consisting of E188P+S242Y, E188P+S242F, E188P+S242H, E188P+S242W, E188P+S242P, E188P+S242I, E188P+S242T, E188P+S242L, E188P+K279W, E188P+K279Y, E188P+K279F, E188P+K279H, E188P+K279I, E188P+K279L, E188P+K279D, E188P+K279M, E188P+K279S, E188P+K279T E188P+K279N, E188P+K279Q, E188P+K279V, E188P+K279A, E188P+N275F, E188P+N275Y, E188P+N275W, and E188P+N275H, wherein the variant has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to a parent alpha amylase selected from the group consisting of: SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO:
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: May 10, 2022
    Assignee: NOVOZYMES A/S
    Inventors: Carsten Andersen, Vasudeva Prahlada Rao, Rakhi Saikia, Vivek Srivastava, Kendra Darlene Stallings
  • Alpha-amylase variants and polynucleotides encoding same
    Patent number: 11319509
    Abstract: The present invention relates to alpha-amylase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: April 14, 2020
    Date of Patent: May 3, 2022
    Assignee: NOVOZYMES A/S
    Inventors: Carsten Andersen, Chakshusmathi Ghadiyaram, Rajendra Kulothungan Sainathan, Padmavathi Balumuri, Padma Venkatachalam Iyer, Iben Damager, Astrid Munch, Sohel Dalal
  • CLEANING COMPOSITIONS COMPRISING AMYLASE VARIANTS
    Publication number: 20220089976
    Abstract: The present invention relates to cleaning compositions comprising variants of an alpha-amylase and methods of treating surfaces such as textiles with aqueous liquor comprising such compositions, especially at low temperatures.
    Type: Application
    Filed: December 9, 2021
    Publication date: March 24, 2022
    Inventors: Carsten ANDERSEN, Chakshusmathi GHADIYARAM, Madhupriya MAHANKALI, Rajendra Kulothungan SAINATHAN, Montserrat Guadalupe VASQUEZ VALDIVIESO
  • Stabilized alpha-amylase variants and use of the same
    Patent number: 11248193
    Abstract: The present invention relates to alpha-amylase variants having an improved stability as compared to the parent alpha-amylase. The invention further relates to use of the variants, compositions comprising the variants, and methods of producing the variants.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: February 15, 2022
    Assignee: NOVOZYMES A/S
    Inventors: Carsten Andersen, Anna-Kathrine Fevre
  • ALPHA-AMYLASE VARIANTS HAVING IMPROVED PERFORMANCE AND STABILITY
    Publication number: 20210403890
    Abstract: The present invention relates to alpha-amylase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: September 14, 2021
    Publication date: December 30, 2021
    Applicant: Novozymes A/S
    Inventor: Carsten Andersen
  • Chymotrypsin Inhibitor Variants And The Use Thereof
    Publication number: 20210380667
    Abstract: Disclosed are protease inhibitors capable of inhibiting the protease activity of a S1 or a S8 protease at ambient pH, but where the inhibitor further has a pH dependent binding to the S1 or the S8 inhibitor meaning that a complex of a S1 and a S8 protease and the inhibitor dissociates when pH is lowered to a pH below 6.0, e.g. to a pH value in the range of 4.0 to 6.0; e.g. in the range of 4.5 to 6.0; e.g. in the range of 4.5 to 5.5; whereby the protease activity is released.
    Type: Application
    Filed: October 8, 2019
    Publication date: December 9, 2021
    Applicant: Novozymes A/S
    Inventors: Poul Erik Pedersen, Esben Peter Friis, Carsten Andersen, Peter Rahbek Oestergaard, Johan Qvist
  • Variant polypeptides with improved performance and use of the same
    Patent number: 11186833
    Abstract: The present invention relates to polypeptide variants having alpha-amylase activity and an improved property, such as improved specific activity, as compared to the parent polypeptide. The invention further relates to use of the polypeptide variants, compositions comprising the polypeptide variants, and methods of producing the polypeptide variants.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: November 30, 2021
    Assignee: NOVOZYMES A/S
    Inventor: Carsten Andersen
  • Alpha-amylase variants and polynucleotides encoding same
    Patent number: 11180745
    Abstract: The present invention relates to alpha-amylase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: November 23, 2021
    Assignee: Novozymes A/S
    Inventors: Carsten Andersen, Signe E. Larsen, Esben Peter Friis, Pernille Ollendorff Micheelsen, Anders Viksoee-Nielsen, Randy Deinhammer, Xinyu Shen
  • ALPHA-AMYLASE VARIANTS
    Publication number: 20210355470
    Abstract: The present invention relates to variants of a parent alpha-amylase. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: July 16, 2021
    Publication date: November 18, 2021
    Applicant: Novozymes A/S
    Inventors: Svend Kaasgaard, Jens Oebro, Signe Eskildsen Larsen, Allan Svendsen, Annette Helle Johansen, Michael Skjoet, Carsten Andersen, Lars Beier, Esben Peter Friis, Miguel Duarte Guilherme Pereira Toscano, Mads Bjoernvad, Frank Winther Rasmussen, Liv Spaanger Christiansen
  • Alpha-amylase variants and polynucleotides encoding same
    Patent number: 11174472
    Abstract: The present invention relates to alpha-amylase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: November 16, 2021
    Assignee: Novozymes A/S
    Inventors: Carsten Andersen, Signe E. Larsen, Esben P. Friis, Peter Kamp Hansen, Henrik Friis-Madsen, Anders Viksoee-Nielsen, Pernille O. Micheelsen
  • Alpha-Amylase Variants and Polynucleotides Encoding Same
    Publication number: 20210292723
    Abstract: The present invention relates to alpha-amylase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: November 29, 2017
    Publication date: September 23, 2021
    Applicant: Novozymes A/S
    Inventors: Thomas Gibbons, Carsten Andersen, Prahlada Vasudeva Rao
  • DETERGENT COMPOSITION COMPRISING PROTEASE AND AMYLASE VARIANTS
    Publication number: 20210269750
    Abstract: The present invention relates to detergent compositions comprising protease variants and alpha-amylases or variants thereof. Furthermore, the present invention relates to methods of using the detergent compositions.
    Type: Application
    Filed: May 6, 2021
    Publication date: September 2, 2021
    Applicant: NOVOZYMES A/S
    Inventors: Carsten Andersen, Yanfei Wang, Wenwen Tao, Bitten Plesner, Elena Genesca Pont
  • Alpha-amylase variants
    Patent number: 11091748
    Abstract: The present invention relates to variants of a parent alpha-amylase. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: July 14, 2020
    Date of Patent: August 17, 2021
    Assignee: NOVOZYMES A/S
    Inventors: Svend Kaasgaard, Jens Oebro, Signe Eskildsen Larsen, Allan Svendsen, Annette Helle Johansen, Michael Skjoet, Carsten Andersen, Lars Beier, Esben Peter Friis, Miguel Duarte Guilherme Pereira Toscano, Mads Bjoernvad, Frank Winther Rasmussen, Liv Spaanger Christiansen
  • Alpha-amylase variants and polynucleotides encoding same
    Patent number: 11072786
    Abstract: The present invention relates to alpha-amylase variants with improved stability in the presence of glucose and/or relatively higher activity on long chain versus short chain substrates. The present encoding invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: July 27, 2021
    Assignee: Novozymes A/S
    Inventors: Carsten Andersen, Paria Saunders
  • ALPHA-AMYLASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
    Publication number: 20210189364
    Abstract: The present invention relates to alpha-amylase variants comprising a substitution at a position corresponding to position 188 and at least one further substitution at a position corresponding to position 242 or 279 or 275 of SEQ ID NO: 1, in particular one or more combinations of substitutions selected from the group consisting of E188P+S242Y, E188P+S242F, E188P+S242H, E188P+S242W, E188P+S242P, E188P+S242I, E188P+S242T, E188P+S242L, E188P+K279W, E188P+K279Y, E188P+K279F, E188P+K279H, E188P+K279I, E188P+K279L, E188P+K279D, E188P+K279M, E188P+K279S, E188P+K279T E188P+K279N, E188P+K279Q, E188P+K279V, E188P+K279A, E188P+N275F, E188P+N275Y, E188P+N275W, and E188P+N275H, wherein the variant has at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, but less than 100% sequence identity to a parent alpha amylase selected from the group consisting of: SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO:
    Type: Application
    Filed: December 7, 2018
    Publication date: June 24, 2021
    Applicant: NOVOZYMES A/S
    Inventors: Carsten Andersen, Vasudeva Prahlada Rao, Rakhi Saikia, Vivek Srivastava, Kendra Darlene Stallings
  • BETA-GLUCANASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
    Publication number: 20210171927
    Abstract: The present invention relates to beta-glucanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: January 27, 2017
    Publication date: June 10, 2021
    Applicant: NOVOZYMES A/S
    Inventors: Carsten Andersen, Iben Damager, Morten Gjermansen
  • Detergent composition comprising protease and amylase variants
    Patent number: 11028346
    Abstract: The present invention relates to detergent compositions comprising protease variants and alpha-amylases or variants thereof. Furthermore, the present invention relates to methods of using the detergent compositions.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: June 8, 2021
    Assignee: NOVOZYMES A/S
    Inventors: Carsten Andersen, Yanfei Wang, Wenwen Tao, Bitten Plesner, Elena Genesca Pont
  • OXIDATION STABLE ALPHA-AMYLASE VARIANTS
    Publication number: 20200399624
    Abstract: The present invention relates to oxidation stable alpha-amylase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: September 9, 2020
    Publication date: December 24, 2020
    Applicant: NOVOZYMES A/S
    Inventors: Carsten Andersen, Anne Dorte Houg, Signe Eskildsen Larsen, Ali Fallah-Araghi